Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis

Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis

(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of this recombinant antithrombin on the glycocalyx dama...

Full description

Bibliographic Details
Main Authors:	Toshiaki Iba, Jerrold H. Levy, Koichiro Aihara, Katsuhiko Kadota, Hiroshi Tanaka, Koichi Sato, Isao Nagaoka
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	International Journal of Molecular Sciences
Subjects:	antithrombin endothelium glycocalyx syndecan-1 hyaluronan
Online Access:	https://www.mdpi.com/1422-0067/22/1/176

Similar Items

Glycocalyx–Sodium Interaction in Vascular Endothelium
by: Lawrence Fred Sembajwe, et al.
Published: (2023-06-01)

Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis
by: Jiayun Ying, et al.
Published: (2023-08-01)

Endothelial cell activation and glycocalyx shedding - potential as biomarkers in patients with lupus nephritis
by: Susan Yung, et al.
Published: (2023-10-01)

Basal endothelial glycocalyx’s response to shear stress: a review of structure, function, and clinical implications
by: Zoe Vittum, et al.
Published: (2024-03-01)

Endothelial Glycocalyx as a Regulator of Fibrotic Processes
by: Valentina Masola, et al.
Published: (2021-03-01)

High Preoperative Serum Syndecan-1, a Marker of Endothelial Glycocalyx Degradation, and Severe Acute Kidney Injury after Valvular Heart Surgery
by: Hye-Bin Kim, et al.
Published: (2020-06-01)

The Endothelial Glycocalyx and Neonatal Sepsis
by: Ahlam Fatmi, et al.
Published: (2022-12-01)

Loss of Endothelial Glycocalyx Hyaluronan Impairs Endothelial Stability and Adaptive Vascular Remodeling after Arterial Ischemia
by: Gangqi Wang, et al.
Published: (2020-03-01)

Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
by: Duoduo Zha, et al.
Published: (2022-06-01)

Circulating concentrations of glycocalyx degradation products in preeclampsia
by: Niclas Carlberg, et al.
Published: (2022-10-01)

Effect of intravenous fluid volume on biomarkers of endothelial glycocalyx shedding and inflammation during initial resuscitation of sepsis
by: Stephen Macdonald, et al.
Published: (2023-04-01)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-11-01)

Mass intraoperative endothelial glycocalyx shedding affects postoperative systemic inflammation response
by: JiaWan Wang, et al.
Published: (2024-02-01)

Endothelial glycocalyx injury is involved in heatstroke-associated coagulopathy and protected by N-acetylcysteine
by: Na Peng, et al.
Published: (2023-06-01)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)

Hirudins : antithrombin anticoagulants/
by: 245873 Stringer, Kathleen A., et al.

Intramuscular Exposure to a Lethal Dose of Ricin Toxin Leads to Endothelial Glycocalyx Shedding and Microvascular Flow Abnormality in Mice and Swine
by: Anita Sapoznikov, et al.
Published: (2021-11-01)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
by: Réka Gindele, et al.
Published: (2021-04-01)

Biological Effects of Intravenous Vitamin C on Neutrophil Extracellular Traps and the Endothelial Glycocalyx in Patients with Sepsis-Induced ARDS
by: Xian Qiao, et al.
Published: (2022-10-01)

The Role of BAR Proteins and the Glycocalyx in Brain Endothelium Transcytosis
by: Diana M. Leite, et al.
Published: (2020-12-01)

Association between intravenous fluid administration and endothelial glycocalyx shedding in humans: a systematic review
by: Sara Sukudom, et al.
Published: (2024-02-01)

Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?
by: Marina M. Ziganshina, et al.
Published: (2020-04-01)

Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
by: Richard Vollenberg, et al.
Published: (2021-11-01)

Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)

Effects of Chronic Kidney Disease on Nanomechanics of the Endothelial Glycocalyx Are Mediated by the Mineralocorticoid Receptor
by: Benedikt Fels, et al.
Published: (2022-09-01)

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
by: Cornelia Englisch, et al.
Published: (2022-12-01)

Effect of sevoflurane-remifentanil and propofol-remifentanil anesthesia on glycocalyx shedding during deep inferior epigastric perforator flap breast reconstruction: a prospective randomized, controlled trial
by: Bahn Lee, et al.
Published: (2023-04-01)

Vascular Endothelial Glycocalyx Damage in COVID-19
by: Minako Yamaoka-Tojo
Published: (2020-12-01)

The Endothelial Glycocalyx and Organ Preservation—From Physiology to Possible Clinical Implications for Solid Organ Transplantation
by: Simon Mathis, et al.
Published: (2021-04-01)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-05-01)

Aldosterone: Essential for Life but Damaging to the Vascular Endothelium
by: Michael Crompton, et al.
Published: (2023-06-01)

Editorial: Endothelial activation and microcirculatory disorders in sepsis and critical illness
by: Jérémie Joffre, et al.
Published: (2023-01-01)

Links between Endothelial Glycocalyx Changes and Microcirculatory Parameters in Septic Patients
by: Egle Belousoviene, et al.
Published: (2021-08-01)

Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
by: Sarah Gaudette, et al.
Published: (2023-07-01)

Antithrombin and Its Role in Host Defense and Inflammation
by: Christine Schlömmer, et al.
Published: (2021-04-01)

Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19
by: Quan Zhang, et al.
Published: (2023-01-01)

The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis
by: Elina Ghondaghsaz, et al.
Published: (2023-08-01)

Syndecan-1 as a severity biomarker for patients with trauma
by: Keiko Suzuki, et al.
Published: (2022-09-01)

Global trends in research on endothelial cells and sepsis between 2002 and 2022: A systematic bibliometric analysis
by: Yue Shi, et al.
Published: (2024-01-01)

Transient deficiency of antithrombin during pregnancy in a woman with a history of reproductive losses
by: L. O. Buzyan, et al.
Published: (2018-08-01)